Exponent Financial Statements
NASDAQ: EXPOConsumer DiscretionaryProfessional ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Exponent revenue and earnings
In fiscal 2025, Exponent generated $582.0 million in revenue, up 4.2% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $106.0 million (-2.7% year over year), for a net margin of 18.2% versus a median of 19.9% in the prior 5 years. Operating margin was 20.6%.
Diluted earnings per share came in at $2.07, down from $2.11. Over the last 5 fiscal years, EXPO's revenue has grown at a 7.8% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Exponent income statement (annual)
| Fiscal year (USD) | FY 20252026-01-02 | FY 20242025-01-03 | FY 20232023-12-29 | FY 20222022-12-30 | FY 20212021-12-31 | FY 20202021-01-01 | FY 20192020-01-03 | FY 20182018-12-28 | FY 20172017-12-29 | FY 20162016-12-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 582.01M | 558.51M | 536.77M | 513.29M | 466.27M | 399.90M | 417.20M | 379.52M | 347.80M | 315.08M |
| Revenue growth (YoY) | +4.21% | +4.05% | +4.57% | +10.09% | +16.60% | -4.15% | +9.93% | +9.12% | +10.39% | +0.72% |
| Operating Expenses | 462.23M | 438.96M | 425.44M | 372.45M | 357.34M | 316.65M | 332.09M | 288.07M | 275.75M | 253.16M |
| Operating Income | 119.79M | 119.56M | 111.32M | 140.84M | 108.93M | 83.25M | 85.11M | 91.46M | 72.05M | 61.91M |
| Other Income (Expense) | 18.20M | 17.81M | 17.42M | -10.70M | 16.84M | 11.98M | 15.17M | -890.00K | 9.16M | 6.53M |
| Pretax Income | 147.30M | 147.37M | 135.90M | 132.23M | 125.84M | 96.94M | 104.19M | 93.32M | 82.51M | 69.12M |
| Income Tax | 41.29M | 38.37M | 35.56M | 29.90M | 24.64M | 14.38M | 21.73M | 21.06M | 41.20M | 21.64M |
| Net Income | 106.01M | 109.00M | 100.34M | 102.33M | 101.20M | 82.55M | 82.46M | 72.25M | 41.30M | 47.48M |
| Net Income growth (YoY) | -2.75% | +8.63% | -1.95% | +1.11% | +22.59% | +0.11% | +14.13% | +74.93% | -13.01% | +8.90% |
| EPS (Basic) | 2.08 | 2.13 | 1.96 | 1.98 | 1.92 | 1.58 | 1.56 | 1.37 | 0.78 | 0.90 |
| EPS (Diluted) | 2.07 | 2.11 | 1.94 | 1.96 | 1.90 | 1.55 | 1.53 | 1.33 | 0.77 | 0.87 |
| Shares Outstanding (Basic) | 50.90M | 51.13M | 51.15M | 51.73M | 52.61M | 52.39M | 52.69M | 52.91M | 52.72M | 52.98M |
| Shares Outstanding (Diluted) | 51.24M | 51.57M | 51.63M | 52.28M | 53.33M | 53.32M | 53.88M | 54.17M | 53.97M | 54.33M |
| EBITDA | 129.87M | 129.25M | 120.24M | 147.92M | 115.41M | 90.12M | 91.92M | 97.75M | 78.34M | 68.04M |
| Operating Margin | 20.58% | 21.41% | 20.74% | 27.44% | 23.36% | 20.82% | 20.40% | 24.10% | 20.72% | 19.65% |
| Net Margin | 18.21% | 19.52% | 18.69% | 19.94% | 21.70% | 20.64% | 19.77% | 19.04% | 11.88% | 15.07% |
This table shows 10 annual periods of Exponent's income statement, from FY 2025 back to FY 2016, across 14 line items including revenue, operating expenses, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow EXPO's reporting calendar. What is a income statement?